Tenaya Therapeutics Inc

NASDAQ:TNYA   3:59:51 PM EDT
20.81
+2.01 (+10.69%)
Earnings Announcements

Tenaya Therapeutics Q2 Loss Per Share $13.26

Published: 09/08/2021 20:20 GMT
Tenaya Therapeutics Inc (TNYA) - Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates.
Q2 Loss per Share $13.26.
Tenaya - Expects Current Cash, Cash Equivalents to Be Enough to Fund Its Current Operating Plan at Least Into H2 2023.
Qtrly Loss per Share $13.26.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.84

More details on our Analysts Page.